Literature DB >> 10844001

Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac.

H H Versteeg1, I Hoedemaeker, S H Diks, J C Stam, M Spaargaren, P M van Bergen En Henegouwen, S J van Deventer, M P Peppelenbosch.   

Abstract

Tissue factor (TF), apart from activating the extrinsic pathway of the blood coagulation, is a principal regulator of embryonic angiogenesis and oncogenic neoangiogenesis, but also influences inflammation, leukocyte diapedesis and tumor progression. The intracellular domain of TF lacks homology to other classes of receptors and hence the signaling mechanism is poorly understood. Here we demonstrate that factor VIIa (the natural ligand for TF) induces the activation of the Src family members c-Src, Lyn, and Yes, and subsequently phosphatidylinositol 3-kinase (PI3K), followed by stimulation of c-Akt/protein kinase B as well as the small GTPases Rac and Cdc42. In turn Rac mediates p38 mitogen-activated protein (MAP) kinase activation and cytoskeletal reorganization, whereas factor VIIa-induced p42/p44 MAP kinase stimulation required PI3K enzymatic activity but was not inhibited by dominant negative Rac proteins. We propose that this Src family member/PI3K/Rac-dependent signaling pathway is a major mediator of factor VIIa/TF effects in pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844001     DOI: 10.1074/jbc.M907635199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.

Authors:  Zhi-Chao Jia; Yuan-Lian Wan; Jian-Qiang Tang; Yun Dai; Yu-Cun Liu; Xin Wang; Jing Zhu
Journal:  Int J Colorectal Dis       Date:  2011-11-12       Impact factor: 2.571

2.  Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.

Authors:  Janna Dejmek; Annette Säfholm; Christian Kamp Nielsen; Tommy Andersson; Karin Leandersson
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 3.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 4.  Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

Authors:  Giovanni Cimmino; Plinio Cirillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

Review 5.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Authors:  Nicole M Kuderer; Thomas L Ortel; Charles W Francis
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

Review 6.  Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways.

Authors:  Henri H Versteeg; C Arnold Spek; Maikel P Peppelenbosch; Dick J Richel
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

7.  Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.

Authors:  Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2007-03-23       Impact factor: 22.113

8.  Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.

Authors:  Keren Borensztajn; Jurriën Stiekema; Sebastiaan Nijmeijer; Pieter H Reitsma; Maikel P Peppelenbosch; C Arnold Spek
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro.

Authors:  Jian-Quan Zhang; Yuan-Lian Wan; Yu-Cun Liu; Xin Wang; Jian-Qiang Tang; Tao Wu; Jing Zhu; Yi-Sheng Pan
Journal:  Int J Colorectal Dis       Date:  2008-06-12       Impact factor: 2.571

Review 10.  Tissue factor, protease activated receptors and pathologic heart remodelling.

Authors:  Silvio Antoniak; Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.